Sarepta stock falls on FDA gene therapy Elevidys comment
Douglas Ingram, president and chief executive officer of Sarepta Therapeutics Inc., during the Forbes Healthcare Summit in New…
FDA to consider drug affordability when speeding up approvals: Makary
The Food and Drug Administration will consider drug affordability when granting companies new vouchers that speed up approvals…
FDA requires updated warning about rare heart risk with COVID shots
WASHINGTON (AP) — The Food and Drug Administration said Wednesday it has expanded existing warnings on the two…